Your browser doesn't support javascript.
loading
Matriptase as a potential biomarker and therapeutic target in newly diagnosed type 2 diabetes mellitus.
Demir, Ismail; Yilmaz, Ismail; Horoz, Ersan; Calik, Bulent; Bilgir, Oktay.
  • Demir I; Department of Internal Medicine, Health Sciences University, Izmir, Bozyaka Training and Research Hospital, 35170, Karabaglar, Izmir, Turkey. dr.ismail.demir.36@gmail.com.
  • Yilmaz I; Faculty of Medicine, Department of Pharmacology and Toxicology, Izmir Kâtip Celebi University, Izmir, Turkey.
  • Horoz E; Faculty of Medicine, Department of Pharmacology and Toxicology, Izmir Kâtip Celebi University, Izmir, Turkey.
  • Calik B; Department of General Surgery, Health Sciences University Izmir, Bozyaka Training and Research Hospital, Izmir, Turkey.
  • Bilgir O; Department of Internal Medicine, Health Sciences University, Izmir, Bozyaka Training and Research Hospital, 35170, Karabaglar, Izmir, Turkey.
Ir J Med Sci ; 193(1): 223-230, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37418107
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Resistencia a la Insulina / Síndrome Metabólico / Diabetes Mellitus Tipo 2 Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Resistencia a la Insulina / Síndrome Metabólico / Diabetes Mellitus Tipo 2 Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article